Clinical trial · Observational
Nexium Capsules Clinical Experience Investigation
NCT01434485CI-TRIAL-00014276completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to confirm the safety profile / factors which impact safety and efficacy of Nexium capsules in daily clinical usage for the patients who have been prescribed Nexium for "gastric ulcer", "duodenal ulcer", "anastomotic ulcer", "reflux oesophagitis", "non-erosive reflux disease", or "Zollinger-Ellison syndrome"
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Ulcer, Duodenal Ulcer, Anastomotic Ulcer, Reflux Oesophagitis,"Non-erosive Reflux Disease, Zollinger-Ellison Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Nexium
Primary outcomes (4)
- measure
- Number of Adverse Drug Reactions
- timeFrame
- Patients with gastric ulcer, anastomotic ulcer or Zollinger-Ellison syndrome: 8 weeks
- measure
- Number of Adverse Drug Reactions
- timeFrame
- Patients with duodenal ulcer: 6 weeks
- measure
- Number of Adverse Drug Reactions
- timeFrame
- Patients with reflux oesophagitis: 8 weeks
- measure
- Number of Adverse Drug Reactions
- timeFrame
- Patients with non-erosive reflux disease: 4 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: - Patients treated with Nexium for the first time due to gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, Zollinger-Ellison syndrome. Exclusion Criteria: - None
References
Publications (0)
Data not yet available
No reference posted for this study.